Polen Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,917
Closed -$238K 280
2025
Q2
$238K Sell
1,917
-28,985
-94% -$3.69M ﹤0.01% 236
2025
Q1
$3.93M Sell
30,902
-9,654
-24% -$1.49M 0.01% 66
2024
Q4
$5.84M Buy
40,556
+5,173
+15% +$742K 0.02% 62
2024
Q3
$5.27M Buy
35,383
+20,811
+143% +$2.98M 0.01% 60
2024
Q2
$1.84M Buy
+14,572
New +$2.28M ﹤0.01% 88

Other funds holding RGEN

Polen Capital Management's RGEN Position: Q3 2025 in Review

Polen Capital Management sold out of Repligen (RGEN) in Q3 2025, closing a stake of 1,917 shares — an estimated $238K sold.

Polen Capital Management first reported a position in RGEN in Q2 2024 and held it in 5 quarters. The position peaked at $5.84M in Q4 2024. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Polen Capital Management reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
  • Polen Capital Management sold 1,917 Repligen shares in Q3 2025, an estimated $238K.
  • Polen Capital Management first reported a position in Repligen in Q2 2024 and held it in 5 quarters.
  • Polen Capital Management's Repligen position peaked at $5.84M in Q4 2024.
  • 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Polen Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.